Interactions between Alzheimer's disease and cerebral ischemia—focus on inflammation
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 48 (2) , 240-250
- https://doi.org/10.1016/j.brainresrev.2004.12.014
Abstract
No abstract availableKeywords
This publication has 151 references indexed in Scilit:
- Lack of apolipoprotein E dramatically reduces amyloid β-peptide depositionNature Genetics, 1997
- Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl ImidazolesBiochemical and Biophysical Research Communications, 1997
- Spatial learning deficit in mice expressing human 751-amino acid β-amyloid precursor proteinNeuroReport, 1996
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996
- Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brainNeurochemistry International, 1995
- β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityCell, 1995
- Secreted Forms of β‐Amyloid Precursor Protein Protect Against Ischemic Brain InjuryJournal of Neurochemistry, 1994
- Transgenic mouse brain histopathology resembles early Alzheimer's diseaseAnnals of Neurology, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein levelInflammation Research, 1993